Skip to main content
Figure 6 | BMC Cancer

Figure 6

From: Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer

Figure 6

Transfection and apoptosis induction efficiency of combination treatment. (a) mRNA expression profile for p53 and transcription factors in the apoptotic pathway. (n = 6, *p < 0.05; **p < 0.01; ***p < 0.001). (b) Western blot analysis for cleaved PARP, cleaved caspase 3 and β-actin protein expression in treated tumors. (c) TUNEL stained images of treated tumors indicating DNA fragmentation (brown stain). All images were acquired at 20× with scale bar of 50 μm.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us